Izuralimab
Based on 1 Customer Validation
Izuralimab is a bispecific IgG1 antibody targeting inducible T-cell costimulator (ICOS/CD278) and PD-1.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté : 99.97%
- CAS No.: 2329669-80-7
- Masse moléculaire:126.283 kDa
-
Stockage:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
IC50 & Target
PDCD1 & ICOS
Application
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized PD-1 Protein, Human (143a.a, HEK293, His, HY-P7396) can bind Izuralimab. The EC50 for this effect is 8.806 ng/mL. -
Immobilized ICOS Protein, Human (HEK293, Fc, HY-P72618) can bind Izuralimab. The EC50 for this effect is 62.25 ng/mL.
Product Details
-
CAS No. 2329669-80-7
-
Masse moléculaire 126.283 kDa
-
Species Reactivity
Human
-
Conjugated
Unconjugated
-
Isotype
half-IGG1-kappa/(scFv-kappa-heavy)-h-CH2-CH3
-
Recommend Isotype Controls
-
Format
-
half-IGG1-kappa/(scFv-kappa-heavy)-h-CH2-CH3
-
Product Properties
-
Appearance
Liquid
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Pureté
99.97%
-
Reconstitution
The product can be reconstituted/diluted with sterile PBS or saline.
-
Storage & Stability
Please store the product under the recommended conditions in the Certificate of Analysis.
-
Livraison
Shipping with dry ice.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)